Microneedle array sensor applicator device

Information

  • Patent Grant
  • D1033641
  • Patent Number
    D1,033,641
  • Date Filed
    Friday, December 17, 2021
    3 years ago
  • Date Issued
    Tuesday, July 2, 2024
    10 months ago
  • Inventors
    • Morelock; David Michael (Escondido, CA, US)
  • Original Assignees
  • Examiners
    • Lawrence; Samantha Q
    • Wong; Thanh Luu
    Agents
    • Cooley LLP
  • US Classifications
    Field of Search
    • US
    • D24 107
    • D24 108
    • D24 112
    • D24 130
    • D24 133
    • D24 146
    • D24 147
    • D24 186
    • D15 72
    • D15 78
    • D28 7
    • D09 772
    • D09 773
    • D09 774
    • D09 777
    • CPC
    • A61M37/0015
    • A61M2037/0038
    • A61M2037/0053
    • A61M2037/003
    • A61M2037/0023
    • A61M2037/0061
    • A61M2207/00
    • A61M2037/0046
    • A61N1/328
    • A61B5/145
    • A61B5/14503
  • International Classifications
    • 2402
    • Term of Grant
      15Years
Abstract
Description


FIG. 1 is a front perspective view of a microneedle array sensor applicator device showing the new design;



FIG. 2 is a front view thereof;



FIG. 3 is a right side view thereof;



FIG. 4 is a rear view thereof;



FIG. 5 is a left side view thereof;



FIG. 6 is a top plan view thereof; and,



FIG. 7 is a bottom plan view thereof.


The broken lines illustrate portions of the microneedle array sensor applicator device that form no part of the claimed design.


Claims
  • The ornamental design for a microneedle array sensor applicator device, as shown and described.
US Referenced Citations (175)
Number Name Date Kind
D178118 Enos Jun 1956 S
D315914 Chen Apr 1991 S
D438794 Miles Mar 2001 S
D444594 Angeletta Jul 2001 S
6855131 Trautman et al. Feb 2005 B2
7097631 Trautman et al. Aug 2006 B2
D544298 Eide Jun 2007 S
7582059 Funderburk et al. Sep 2009 B2
7946984 Brister et al. May 2011 B2
8094009 Allen et al. Jan 2012 B2
8125331 Allen et al. Feb 2012 B2
8130095 Allen et al. Mar 2012 B2
8175673 Say et al. May 2012 B2
8252229 Thomas et al. Aug 2012 B2
8267889 Cantor et al. Sep 2012 B2
8280475 Brister et al. Oct 2012 B2
8284046 Allen et al. Oct 2012 B2
D681877 Curry May 2013 S
8579862 Kobayashi et al. Nov 2013 B2
8652043 Drucker et al. Feb 2014 B2
8753318 Trautman et al. Jun 2014 B2
8758298 Cantor et al. Jun 2014 B2
8764657 Curry et al. Jul 2014 B2
8821446 Trautman et al. Sep 2014 B2
D717100 Moser Nov 2014 S
9008745 Pushpala et al. Apr 2015 B2
9055901 Brister et al. Jun 2015 B2
9101305 Larson et al. Aug 2015 B2
9119945 Simons et al. Sep 2015 B2
9174035 Ringsred et al. Nov 2015 B2
9215992 Donnay et al. Dec 2015 B2
9357951 Simpson et al. Jun 2016 B2
9402544 Yee et al. Aug 2016 B2
9402570 Pace et al. Aug 2016 B2
9415198 McAllister Aug 2016 B2
9492647 Stumber et al. Nov 2016 B2
9610401 Antonio et al. Apr 2017 B2
9615779 Pryor et al. Apr 2017 B2
9636060 Feldman et al. May 2017 B2
9642568 Shah et al. May 2017 B2
9687640 Trautman et al. Jun 2017 B2
9717843 Grucela et al. Aug 2017 B2
9737247 Wang et al. Aug 2017 B2
9743870 Wang et al. Aug 2017 B2
9782574 Simmers Oct 2017 B2
9789249 Frederickson et al. Oct 2017 B2
9814414 Brister et al. Nov 2017 B2
D806254 Im Dec 2017 S
9844328 Simpson et al. Dec 2017 B2
9933387 McCanna et al. Apr 2018 B1
9949642 Love et al. Apr 2018 B2
9968742 Van Antwerp et al. May 2018 B2
10010280 Donnay et al. Jul 2018 B2
10010707 Colburn et al. Jul 2018 B2
D827682 Anderson Sep 2018 S
10092207 Windmiller Oct 2018 B1
10136846 Wang et al. Nov 2018 B2
10213139 Rao et al. Feb 2019 B2
10213141 Cole et al. Feb 2019 B2
10278732 Schoonmaker et al. May 2019 B2
10300260 Wirtanen et al. May 2019 B2
10406339 Simmers Sep 2019 B2
10413183 Antonio et al. Sep 2019 B2
10492685 Bernstein et al. Dec 2019 B2
10492708 Windmiller Dec 2019 B1
D875254 Cooke et al. Feb 2020 S
10595754 Pushpala et al. Mar 2020 B2
10596295 Larson et al. Mar 2020 B2
10674944 Pace Jun 2020 B2
10709834 Chiu et al. Jul 2020 B2
10863944 Gray et al. Dec 2020 B2
10898115 Halac et al. Jan 2021 B2
10932699 Lin et al. Mar 2021 B2
10973443 Funderburk et al. Apr 2021 B2
10993646 Scott et al. May 2021 B2
11045142 Windmiller et al. Jun 2021 B1
D924406 Yee Jul 2021 S
11058329 Simpson et al. Jul 2021 B2
11071478 Rao et al. Jul 2021 B2
D928119 Walter Aug 2021 S
11122043 Love et al. Sep 2021 B2
11172851 Pushpala et al. Nov 2021 B2
11357430 Pushpala et al. Jun 2022 B2
11406818 Windmiller Aug 2022 B2
11517222 Pushpala et al. Dec 2022 B2
D980986 Rao Mar 2023 S
11654270 Mansfield et al. May 2023 B2
D988160 Morelock Jun 2023 S
11672965 Mansfield et al. Jun 2023 B2
D996999 Morelock Aug 2023 S
D997362 Donnay Aug 2023 S
D999913 Rao Sep 2023 S
D1006235 Rao Nov 2023 S
D1008021 Jensen Dec 2023 S
20020087182 Trautman et al. Jul 2002 A1
20040236251 Roe Nov 2004 A1
20050096586 Trautman et al. May 2005 A1
20050283114 Bresina Dec 2005 A1
20080114280 Stafford May 2008 A1
20080183144 Trautman et al. Jul 2008 A1
20080242961 Brister et al. Oct 2008 A1
20100056873 Allen et al. Mar 2010 A1
20110082484 Saravia et al. Apr 2011 A1
20110106126 Love et al. May 2011 A1
20110190603 Stafford Aug 2011 A1
20110191044 Stafford Aug 2011 A1
20110319729 Donnay et al. Dec 2011 A1
20120123387 Gonzalez et al. May 2012 A1
20120197222 Donnay et al. Aug 2012 A1
20120303043 Donnay Nov 2012 A1
20140275907 Feldman et al. Sep 2014 A1
20140330209 Frederickson et al. Nov 2014 A1
20140336487 Wang et al. Nov 2014 A1
20150173661 Myles Jun 2015 A1
20150351674 Thomas et al. Dec 2015 A1
20160029931 Salas-Boni et al. Feb 2016 A1
20170361079 Trautman et al. Dec 2017 A1
20180317820 Pace et al. Nov 2018 A1
20190059796 Larson et al. Feb 2019 A1
20190120785 Halac et al. Apr 2019 A1
20190125223 Wang et al. May 2019 A1
20190133501 Rao et al. May 2019 A1
20190133510 El Kaliouby et al. May 2019 A1
20190239825 Kumar et al. Aug 2019 A1
20190309433 Sattayasamitsathit et al. Oct 2019 A1
20190336053 Halac et al. Nov 2019 A1
20190339224 Bhavaraju et al. Nov 2019 A1
20200037939 Castagna et al. Feb 2020 A1
20200085341 Windmiller Mar 2020 A1
20200101286 Windmiller et al. Apr 2020 A1
20200138346 Brister et al. May 2020 A1
20200178853 Pushpala et al. Jun 2020 A1
20200209179 Bohm et al. Jul 2020 A1
20200214566 Allen et al. Jul 2020 A1
20200254240 Windmiller et al. Aug 2020 A1
20200297997 Windmiller et al. Sep 2020 A1
20200330010 Barry et al. Oct 2020 A1
20200375455 Van Tassel et al. Dec 2020 A1
20210000399 Curry et al. Jan 2021 A1
20210007651 Donnay et al. Jan 2021 A1
20210038131 Li et al. Feb 2021 A1
20210076987 Stafford Mar 2021 A1
20210133126 Yamakita et al. May 2021 A1
20210142912 Belliveau et al. May 2021 A1
20210186425 Rodriguez et al. Jun 2021 A1
20210187286 Windmiller et al. Jun 2021 A1
20210196162 Halac et al. Jul 2021 A1
20210204841 Thomas et al. Jul 2021 A1
20210219877 Baker et al. Jul 2021 A1
20210236057 Pushpala et al. Aug 2021 A1
20210260257 McCanless et al. Aug 2021 A1
20210308009 Cho et al. Oct 2021 A1
20210315493 Pace et al. Oct 2021 A1
20210321914 Brister et al. Oct 2021 A1
20210321942 Pushpala et al. Oct 2021 A1
20210379370 Windmiller Dec 2021 A1
20210393201 Morelock et al. Dec 2021 A1
20220031209 Windmiller et al. Feb 2022 A1
20220031244 Windmiller et al. Feb 2022 A1
20220079481 Pushpala et al. Mar 2022 A1
20220080678 Cole et al. Mar 2022 A1
20220087610 Pushpala et al. Mar 2022 A1
20220125344 Pushpala et al. Apr 2022 A1
20220151516 Wang et al. May 2022 A1
20220175278 Campbell et al. Jun 2022 A1
20220370011 Windmiller et al. Nov 2022 A1
20230033467 Pushpala et al. Feb 2023 A1
20230074798 Tangney Mar 2023 A1
20230094419 Mansfield, III et al. Mar 2023 A1
20230099617 Mansfield, III et al. Mar 2023 A1
20230137258 Windmiller May 2023 A1
20230190147 Campbell et al. Jun 2023 A1
20230256220 Mansfield, III et al. Aug 2023 A1
20230301552 Mallires et al. Sep 2023 A1
20230310823 Mansfield, III et al. Oct 2023 A1
Foreign Referenced Citations (17)
Number Date Country
2015227515 May 2017 AU
2 532 305 Dec 2012 EP
D1707722 Feb 2022 JP
WO-2007097754 Aug 2007 WO
WO-2013066854 May 2013 WO
WO-2014055456 Apr 2014 WO
WO-2018071265 Apr 2018 WO
WO-2019084023 May 2019 WO
WO-2019236859 Dec 2019 WO
WO-2019236876 Dec 2019 WO
WO-2020231405 Nov 2020 WO
WO-2021101857 May 2021 WO
WO-2021158372 Aug 2021 WO
WO-2021257624 Dec 2021 WO
WO-2023055755 Apr 2023 WO
WO-2023064877 Apr 2023 WO
WO-2023133468 Jul 2023 WO
Non-Patent Literature Citations (55)
Entry
Freestyle Libre 3 Sensor, usmeddirect.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https://www.usmeddirect.com/products/freestyle-libre-3-sensor-prescription-required (Year: 2023).
Dexcom G7 Sensor, pharmalynk.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https://store.pharmalynk.com/products/dexcom-g7-cgm (Year: 2023).
Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
American Diabetes Association® Press Release (2020). “American Diabetes Association® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
Dexcom (2020). Analyst Day Presentation, 19 total pages.
Dexcom (2020). Analyst Day Presentation, 27 total pages.
Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study),” J. Diab. Scl. Tech. 12:1211-1219.
Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
International Search Report mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 2 pages.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring with Glycemic Control and Acute Metabolic Events Among Patients with Insulin-Treated Diabetes,” JAMA 325:2273-2284.
Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin a Randomized Clinical Trial,” JAMA 325:2262-2272.
McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Blomed. Optics 9:274-281.
Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
Written Opinion of the International Searching Authority mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 6 pages.
Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. doi: 10.7759/cureus.11195.
Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. (2008) Jun. 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
Barrett et al., “Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring ” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
Ehrhardt et al., “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
Ehrhardt et al., “Continuous Glucose Monitoring as a Behavior Modification Tool” Clin Diabetes. Apr. 2020;38(2):126-131. doi: 10.2337/cd19-0037.
Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
International Search Report and Written Opinion mailed on Mar. 20, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 26 pages.
International Search Report and Written Opinion mailed on May 22, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 20 pages.
Invitation to Pay Additional Fees mailed on Jan. 26, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 22 pages.
Invitation to Pay Additional Fees mailed on Mar. 28, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 15 pages.
Non-Final Office Action mailed on Apr. 25, 2023, for U.S. Appl. No. 17/348,651, filed Jun. 15, 2021, 24 pages.
Non-Final Office Action mailed on Dec. 7, 2022, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 7 pages.
Non-Final Office Action mailed on Sep. 8, 2023, for U.S. Appl. No. 18/139,308, filed Apr. 25, 2023, 7 pages.
Notice of Allowance mailed on Jan. 26, 2023, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 9 pages.
Notice of Allowance mailed on Jan. 3, 2023, for U.S. Appl. No. 17/954,293, filed Sep. 27, 2022, 8 pages.
Notice of Allowance mailed on Sep. 12, 2023, for U.S. Appl. No. 18/139,302, filed Apr. 25, 2023, 8 pages.
Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
Written Opinion (Second Opinion) of the International Preliminary Examining Authority mailed on May 25, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 14 pages.
Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients with Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.